Novavax's COVID vaccine to be studied in the US - KRCRTV.COM

by krcrtv 12/28/2020

WASHINGTON (AP) - A huge study of another COVID-19 vaccine candidate is getting underway Monday as states in the U. S. continue to roll out scarce supplies of the nation’s first shot options. The U. S. has authorized the emergency use of two vaccines, one made by Pfizer and BioNTech and the other by Moderna, but doses will be rationed for months. The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the U. S.


image

Travel restrictions are reemerging internationally and domestically in the United States as a popular mitigation tool to try to manage the spread of COVID-19 and new strains of the virus. But with worldwide coronavirus cases surpassing 81 million and the U. S. expecting a post-holiday surge, there are questions about how effective those measures are. Internationally, reports of a new, potentially more transmissible strain of coronavirus in the United Kingdom prompted widespread travel bans.

image

Travel restrictions are reemerging internationally and domestically in the United States as a popular mitigation tool to try to manage the spread of COVID-19 and new strains of the virus. But with worldwide coronavirus cases surpassing 81 million and the U. S. expecting a post-holiday surge, there are questions about how effective those measures are. Internationally, reports of a new, potentially more transmissible strain of coronavirus in the United Kingdom prompted widespread travel bans.